Moderna (Nasdaq: MRNA) today reported financial results and provided business updates for the first quarter of 2025, which ...

US biotech Akari Therapeutics (Nasdaq: AKTX), which is developing novel payload antibody drug conjugates (ADCs), today ...

UK drugmaker GSK ended Tuesday’s trading more than 2% higher after announcing its first-quarter financial results.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bristol Myers Squibb’s (NYSE: BMY) Opdivo ...

Shortly after Robert F Kennedy Jr was sworn in as Secretary of Health and Human Services (HHS), US President Donald Trump ...

US biotech major Biogen (Nasdaq: BIIB) reported stronger-than-expected earnings for the first quarter of 2025, helped by ...

According to property advisor Knight Frank, venture capital (VC) funding into the UK life sciences sector reached £1.1 ...

UK regulators are set to review a proposed label update for Eisai (TYO: 4523) and Biogen’s (Nasdaq: BIIB) Alzheimer’s drug ...

UK investment firm Aviva Capital Partners is supporting a major new life sciences expansion in south London, which aims to ...

UK pharma major GSK (LSE: GSK) has published results from its Phase III MATINEE trial evaluating Nucala (mepolizumab) in ...

US biotech Immunic (Nasdaq: IMUX) has reported top-line results from a mid-stage study of its lead candidate vidofludimus ...

The US Food and Drug Administration (FDA) has approved Imaavy (nipocalimab-aahu), a human FcRn-blocking monoclonal antibody, ...